Kesimpta is an ofatumumab auto-injector therapy for adults with relapsing forms of multiple sclerosis.
Competes with
Novartis
Innovative Swiss-American pharma creating transformative treatments.
- 101.7k
- Public
Founded in March 1996 through the merger of Ciba-Geigy and Sandoz, Novartis Institutes for BioMedical Research (NIBR) is a pioneering pharmaceutical research organization headquartered in Basel, Switzerland. NIBR's core mission is to transform patient care by focusing on unmet medical needs and advancing disease understanding. They specialize in developing innovative pharmaceutical drugs, generic drugs, and over-the-counter treatments. NIBR's unique approach integrates early-stage research with clinical practice to identify and advance the most promising drug candidates through Proof-of-Concept clinical trials.
Notable figures associated with Novartis include CEO Vasant Narasimhan and Chairman Jörg Reinhardt. The organization has achieved significant milestones in drug development and has a substantial impact on global healthcare. Novartis' commitment to innovation and patient-centric research has led to breakthroughs in various therapeutic areas, enhancing the quality of life for millions worldwide. Their work continues to set industry standards and drive advancements in pharmaceutical research and development.
Products & Services
Similar Companies
Provivi
Cyteir Therapeutics
PeptiStar
Neurophth Therapeutics
Tarveda Therapeutics
Therini Bio
Bristol Myers Squibb
bms.com
Amylyx Pharmaceuticals
amylyx.com
Novartis Institutes For Biomedical Research
novartis.com
Novartis Pharma
Lonza
lonza.com
Pfizer
pfizer.com
Roche Holding
roche.com
AstraZeneca
astrazeneca.com
UCB
ucb.com
Quick Facts
Who are Novartis' competitors?
Companies similar to Novartis include Bristol Myers Squibb, Amylyx Pharmaceuticals, Provivi and Cyteir Therapeutics.
When was Novartis founded?
Novartis was founded in 2002.
Where is Novartis' headquarters located?
Novartis' headquarters is located in Basel, Basel-Stadt, CH.
When was Novartis' last funding round?
Novartis' most recent funding round was for $6.5M (USD) in February 2018.
How much disclosed funding has Novartis raised?
As of Feb 14, 2018, Novartis has disclosed funding of $6.5M (USD). Undisclosed round amounts are excluded.
How many employees does Novartis have?
Novartis has 101,703 employees as of Feb 6, 2024.
Classification
- Revenue
- Customer
- Tags
- Ticker
- NVS
- NVSEF
- SEC CIK
- 0001114448
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
Show 21 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 339100Medical Equipment and Supplies Manufacturing
- 339110Medical Equipment and Supplies Manufacturing
- 339115Ophthalmic Goods Manufacturing
- 330000Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 339000Miscellaneous Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
- 3827Optical Instruments And Lenses
- 2800Chemicals And Allied Products
- 3900Miscellaneous Manufacturing Industries
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified